OPKO Health Inc (OPK) (Q3 2026) Earnings Call Highlights: Revenue Climbs 16% as LabCorp Deal ...
OPKO Health Inc (OPK) posted $65.4 million in Q3 2026 revenue and a $722 million LabCorp cash windfall, while widening biotech losses and a delayed CAR-T timeline tempered the outlook. Related Stocks: OPK ,